Turning Point Therapeutics: Q2 Earnings SnapshotAugust 8, 2022 GMT
SAN DIEGO (AP) _ Turning Point Therapeutics Inc. (TPTX) on Monday reported a loss of $123.1 million in its second quarter.
The San Diego-based company said it had a loss of $2.48 per share.
Zumiez, Tesla fall; Okta, Calavo Growers riseJune 3, 2022 GMT
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday:
Turning Point Therapeutics Inc., up $40.43 to $74.59.
Bristol Myers Squibb is buying the biopharmaceutical company for about $4.1 billion.
Turning Point Therapeutics: Q1 Earnings SnapshotMay 10, 2022 GMT
SAN DIEGO (AP) _ Turning Point Therapeutics Inc. (TPTX) on Tuesday reported a loss of $74.4 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of $1.50.